TESTICULAR AND ADRENOCORTICAL FUNCTION IN HEALTHY-MEN AND IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

被引:21
作者
STEGE, R [1 ]
CARLSTROM, K [1 ]
机构
[1] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT OBSTET & GYNECOL,S-14186 HUDDINGE,SWEDEN
关键词
D O I
10.1016/0960-0760(92)90140-E
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The influence of aging upon serum concentrations of testicular steroids, sex hormone binding globulin (SHBG) and pituitary hormones and on adrenal steroid levels and adrenal steroid response to ACTH was studied in 81 healthy men aged 20-87 years. These endocrine variables were also compared in 43 patients with benign prostatic hyperplasia (BPH), aged 58-89 years and in a subgroup of 41 men, aged 58-87 years, from the above mentioned reference population. The normal endocrine aging was characterized by a rise in SHBG levels, decreasing levels of testicular steroid and non-SHBG-bound testosterone (NST) and increasing gonadotropin levels and decreasing concentrations of total estrone. Adrenal androgen levels decreased in the presence of unchanged levels of cortisol and the adrenal steroid response to ACTH changed by decreasing increments in dehydroepiandrosterone (DHA) and increasing increments in 17-alpha-hydroxyprogesterone (17OHP). With the exception of the alterations in SHBG and adrenal androgens, all these changes were finished before the seventh decade of life. BPH patients had elevated levels of testosterone and NST in the presence of normal SHBG and gonadotropin levels, elevated levels of DHA and DHA sulfate (DHAS) in the presence of normal cortisol levels, a "younger" pattern of adrenal steroid response to ACTH as judged from the increments in DHA and 17OHP, elevated ratios between estrone and 4-androstene-3,17-dione suggesting an increased peripheral aromatization and subnormal prolactin levels. BPH patients may be considered as "endocrinologically younger" than healthy subjects. DHA and especially its proximate metabolite 5-androstene-3-beta, 17-beta-diol exert powerful estrogenic effects on the receptor level. Thus the elevated levels of DHA and DHAS in the BPH patients may create an hyperestrogenic condition in addition to the slight hyperandrogenicity caused by the elevated NST levels. Both endocrine aberrations may play a role in the etiology of BPH, in accordance with the dual sex steroid sensitivity of the periurethral glands.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 23 条
[1]   HORMONE BLOOD-LEVELS AND THEIR INTERRELATIONSHIPS IN NORMAL MEN AND MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH) [J].
BARTSCH, W ;
BECKER, H ;
PINKENBURG, FA ;
KRIEG, M .
ACTA ENDOCRINOLOGICA, 1979, 90 (04) :727-736
[2]   CONCENTRATIONS OF 3-BETA-HYDROXY ANDROGENS IN EPITHELIUM AND STROMA OF BENIGN HYPERPLASTIC AND NORMAL HUMAN-PROSTATE [J].
BARTSCH, W ;
KOZAK, I ;
GORENFLOS, P ;
BECKER, H ;
VOIGT, KD .
PROSTATE, 1986, 8 (01) :3-10
[3]   COMPARATIVE-STUDY OF PLASMA STEROID AND STEROID GLUCURONIDE LEVELS IN NORMAL MEN AND IN MEN WITH BENIGN PROSTATIC HYPERPLASIA [J].
BROCHU, M ;
BELANGER, A .
PROSTATE, 1987, 11 (01) :33-40
[4]   RELATIONSHIP BETWEEN SERUM TESTOSTERONE AND SEX HORMONE-BINDING GLOBULIN IN ADULT MEN WITH INTACT OR ABSENT GONADAL-FUNCTION [J].
CARLSTROM, K ;
ERIKSSON, A ;
STEGE, R ;
RANNEVIK, G .
INTERNATIONAL JOURNAL OF ANDROLOGY, 1990, 13 (01) :67-73
[5]   PROGNOSTIC VALUE OF SERUM HORMONE CONCENTRATIONS IN PROSTATIC-CANCER [J].
ERIKSSON, A ;
CARLSTROM, K .
PROSTATE, 1988, 13 (03) :249-256
[6]   HORMONES AND PROSTATE [J].
GRIFFITHS, K .
BRITISH JOURNAL OF CANCER, 1974, 30 (02) :187-188
[7]   CUMULATIVE PREVALENCE OF PROSTATISM MATCHES THE AUTOPSY PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA [J].
GUESS, HA ;
ARRIGHI, HM ;
METTER, EJ ;
FOZARD, JL .
PROSTATE, 1990, 17 (03) :241-246
[8]   SERUM STEROIDS IN NORMAL MALES AND PATIENTS WITH PROSTATIC DISEASES [J].
HAMMOND, GL ;
KONTTURI, M ;
VIHKO, P ;
VIHKO, R .
CLINICAL ENDOCRINOLOGY, 1978, 9 (02) :113-121
[9]   DETERMINATION IN HUMAN MALES OF SPECIFIC TESTOSTERONE AND 5ALPHA-DIHYDROTESTOSTERONE BINDING TO SEX-HORMONE BINDING GLOBULIN BY A DIFFERENTIAL DISSOCIATION TECHNIQUE [J].
HORST, HJ ;
BECKER, H ;
VOIGT, KD .
STEROIDS, 1974, 23 (06) :833-844
[10]  
HORST HJ, 1973, UROL INT, V28, P350